Meet Our Teams

JULIE SAWYER-MONTGOMERY

PRESIDENT, BECKMAN COULTER DIAGNOSTICS

Julie Sawyer Montgomery was appointed president of Beckman Coulter Diagnostics in 2020 where she has led the company to new levels of growth and innovation in clinical diagnostics, motivated by the mission to Relentlessly Reimagine Healthcare, One Diagnosis at a Time. Beckman Coulter Diagnostics is the largest operating company within Danaher’s Diagnostics platform, driven by a passion to help laboratories achieve excellence in their operations and empower doctors who await critical laboratory test results that change and save the lives of patients.

 During her tenure, Beckman Coulter has been recognized as a Top Workplace and Julie was honored by Fierce Pharma as one of the 22 most influential people in the fight against COVID-19.

Prior to her current position, Julie led Beckman Coulter’s developed markets commercial organization, business units and global marketing. Before joining Danaher and Beckman Coulter, Julie served as president of Hospira Infusion Systems, a Pfizer company. Prior to becoming president, Julie’s roles at Hospira included U.S. general management, global marketing, and international sales. Earlier in her career, Julie led marketing strategy for the cardiovascular division of Boston Scientific and served healthcare clients as a project leader for the Boston Consulting Group.

Julie holds a Bachelor of Arts in Economics from Columbia University, a Master of Music from the Eastman School of Music, and a Master of Business Administration from the Harvard Business School. She lives in Orange County, California with her husband and three children.

MARIANNE OVESEN

SENIOR VICE PRESIDENT, GLOBAL OPERATIONS
Marianne joined Beckman Coulter as senior vice president of global operations in 2019. Previously, Marianne served as Vice President of Operations with Radiometer. She joined Radioemeter in 2008 as QA Manager and progressed to Director of QA before taking on the Operations role.

Marianne holds a Masters degree in Food Science from the University of Copenhagen.

VIBEKE HOLST-ANDERSEN 

SENIOR VICE PRESIDENT, LEGAL & GENERAL COUNSEL
Vibeke joined Beckman in June 2019 after more than six years as Radiometer VP Legal and General Counsel. She has also been the Diagnostics Platform Regional Counsel, Europe for three years and the Danaher Russia Counsel four years. Vibeke started her career with 8 years in private practice in Copenhagen, mainly focusing on litigation. Later she became in-house counsel and has experience as a GC in multi-national companies, among others within the diagnostic industry.

Vibeke is licensed to practice law in California and Denmark. 

KATHLEEN ORLAND

SENIOR VICE PRESIDENT & GENERAL MANAGER, CLINICAL CHEMISTRY AND IMMUNOASSAY
Kathleen currently serves as Senior Vice President and General Manager for the Clinical Chemistry Immunoassay (CCIA) Business Unit, leading product strategy and new product development programs across eight global sites. Kathleen began her career journey at Beckman Coulter in 2005 as a Senior Product Manager for Immunoassay. Since then, Kathleen has contributed to our success in a variety of roles, including Director, Immunoassay Product Management; VP, Clinical Chemistry Immunoassay Product Management; VP, Danaher Business System and Global Marketing. Kathleen was instrumental in helping us define our customer value proposition and build launch excellence capability. Kathleen’s extensive industry knowledge and DBS expertise combined with her passion for innovation and solving customer problems drives the CCIA team meet their strategic goals.

Kathleen has a bachelor’s degree in microbiology from University of Illinois at Urbana-Champaign and earned her Medical Technologist MT (ASCP) from NorthShore University HealthSystem in Evanston, Illinois.

TIFFANY MURPHY

VICE PRESIDENT, DANAHER BUSINESS SYSTEM & SPECIAL PROJECTS

Tiffany Murphy is responsible for driving global Danaher Business System (DBS) capability and continuous improvement by linking DBS to Core Value Drivers.  In her role, Tiffany builds sustainable competitive advantage by driving Beckman Coulter’s DBS culture and facilitating policy deployment to reach global breakthrough performance.

Tiffany joined Beckman Coulter in 2000 and brings more than 20 years of diagnostic and life science commercial experience. Most recently, she served as Vice President of Sales, North America, where she led a multi-year sales optimization and effectiveness plan that resulted in solid financial growth, high customer retention and associate engagement. 

Tiffany earned a Bachelor of Arts in Biology from Baylor University and a Master of Business Administration from Texas A&M University.

ANAGH A. VORA, M.D.

CHIEF MEDICAL OFFICER AND SENIOR VICE PRESIDENT, MEDICAL & SCIENTIFIC AFFAIRS

Anagh A. Vora, M.D. is responsible for increasing clinical insight, developing markets for new products and improving medical education.  

Dr. Vora joined Beckman Coulter in 2020. Before joining Beckman Coulter, Dr. Vora served as Head of Medical Affairs for the drug development arm of LabCorp. During his more than 15-year career in the diagnostic and therapeutic space, Dr. Vora gained extensive medical affairs experience focused on the commercialization of novel diagnostics and new treatments to help improve patient health.

Dr. Vora holds a Bachelor of Science in Biology, a Master of Science in Immunology from the University of South Carolina, and an M.D. from the Royal College of Surgeons. Dr. Vora was trained as a pathologist at Washington University at Saint Louis and University of California Los Angeles.

BARRY LYON

PRESIDENT, MICROBIOLOGY
Barry Lyon is President of Beckman Coulter Microbiology, a leader in the accurate detection of emerging antimicrobial resistance.

Barry joined Beckman Coulter in February 2021 from Danaher’s Water Quality Platform, where he most recently served as President of Sea-Bird Scientific. Prior to that, Barry led as Vice President, Global Marketing at Hach, a Danaher operating company. Barry has collaborated extensively with the scientific community in these roles; building on Sea-Bird’s rich history of developing novel solutions for global observation programs in marine research science, and leading Hach’s technical training center and directing regulatory affairs with the U.S. Environmental Protection Agency (EPA) and International Organization for Standardization (ISO). 

He holds a Bachelor of Science in Business from the University of Oregon and a Master of Business Administration from Loyola University Maryland.

ROSS BELL

SENIOR VICE PRESIDENT & CHIEF FINANCIAL OFFICER

Ross Bell is Senior Vice President & Chief Financial Officer overseeing the company’s finance and IT operations.

Ross joined Beckman Coulter in 2017 and most recently served as Vice President, Finance for Beckman Coulter’s Developed Markets and business units. In this role, he strengthened the compliance and accounting function, helped drive operating margin expansion initiatives and supported key product launches while stewarding overall R&D investments. Ross started his career at PricewaterhouseCoopers LLP and then held progressive finance leadership roles at Eastman Kodak Company, Lennox International, and Corning Inc.   

Ross earned his Bachelor of Business Administration in Accounting and his Master of Business Administration from Saint Bonaventure University. 

TOM NEUFELDER

CHIEF TECHNOLOGY OFFICER

Tom Neufelder leads Beckman Coulter’s technology vision, strategy, and plans for growth, including monitoring technology trends, identifying opportunities to drive technological advancement, and sharing best practices across business units.

Prior to joining Beckman Coulter in 2021, Tom served as Chief Technology Officer for MaxQ AI which develops artificial intelligence and machine learning applications for detection of intracranial hemorrhage. Tom has held numerous senior executive positions at various companies including Philips Healthcare and GE Healthcare. He brings more than 35 years of experience in engineering and product development to his role at Beckman Coulter.

Tom holds a Master of Science degree in Electrical Engineering from Johns Hopkins University and a Bachelor of Science degree in Electrical Engineering from Rose-Hulman Institute of Technology.

ZIVJENA VUCETIC, M.D., Ph.D.

CHIEF MEDICAL OFFICER AND SENIOR VICE PRESIDENT, MEDICAL & SCIENTIFIC AFFAIRS
Dr. Vucetic drives the medical affairs strategy and manages the Medical & Scientific Affairs team. She joined Beckman Coulter in 2022 and brings more than 15 years of experience guiding clinical development, clinical operations, and real-world evidence and scientific communication to achieve commercialization and operational excellence.

Before joining Beckman Coulter Diagnostics, Dr. Vucetic served as Senior Vice President, Clinical Affairs for Karius. She has held numerous leadership roles at Ortho-Clinical Diagnostics and Fujirebio.

Dr. Vucetic earned her medical degree from the University of Zagreb School of Medicine in Croatia, a Ph.D. in biochemistry from Temple University, and completed a postdoctoral fellowship at the University of Pennsylvania School of Medicine.

KARAN ARORA

SENIOR VICE PRESIDENT, STRATEGY, MARKETING AND PRODUCT INSIGHTS
Karan collaborates across the organization to lead strategy, business development, and manage the Global Marketing and Product Insights teams. He joined Beckman Coulter in 2022 and brings more than 22 years of experience driving business growth fueled by strategy, business development, data analytics, and digital leadership.

Before joining Beckman Coulter Diagnostics, Karan served as Chief Commercial Digital Officer for AstraZeneca. He has held numerous leadership roles at Abbott Diagnostics, Hospira, Novartis Pharmaceuticals, and McKinsey & Company.

Karan earned his Bachelor of Science in Chemistry and Biology from Drake University, a Master of Information Systems Management from DeVry University, and a Master of Business Administration from Northwestern University.